Variants in STAT5B Associate with Serum TC and LDL-C Levels

  • JW Kornfeld
  • , Aaron Isaacs
  • , V Vitart
  • , JA Pospisilik
  • , T Meitinger
  • , U Gyllensten
  • , JF Wilson
  • , I Rudan
  • , H Campbell
  • , JM Penninger
  • , V Sexl
  • , R Moriggl
  • , Cornelia Duijn
  • , PP Pramstaller
  • , AA Hicks

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

Context: Known genetic variants influencing serum lipid levels do not adequately account for the observed population variability of these phenotypes. The GH/signal transducers and activators of transcription (STAT) signaling pathway is an evolutionary conserved system that exerts strong effects on metabolism, including that of lipids. Research Design and Methods: We analyzed the association of 11 single-nucleotide polymorphisms (SNP) spanning the STAT5B/STAT5A/STAT3 locus with serum lipid levels in six European populations (n = 5162 nondiabetic individuals). Results: After adjustment for age, sex, alcohol use, smoking, and body mass index, we identified STAT5B variants(rs8082391 and rs8064638) in novel association with total cholesterol (TC; P = 0.001 and P = 0.002) and low-density lipoprotein cholesterol (P = 0.002 and P = 0.004) levels. The minor alleles of these single-nucleotide polymorphisms were significantly enriched in hyperlipidemic individuals across the six discovery populations (P = 0.004 and P = 0.006). In transgenic mice deficient for Conclusions: Genetic variants in STAT5B are associated with TC and low-density lipoprotein cholesterol levels among six populations. Mechanistically, STAT5B transcriptionally regulates hepatic cholesterol homeostasis. (J Clin Endocrinol Metab 96: E1496-E1501, 2011)
Original languageUndefined/Unknown
Pages (from-to)E1496-E1501
JournalJournal of Clinical Endocrinology and Metabolism
Volume96
Issue number9
DOIs
Publication statusPublished - 2011

Research programs

  • EMC NIHES-01-64-02

Cite this